Mirae Asset Global ETFs Holdings
ACAD icon

Mirae Asset Global ETFs Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.9M Buy
86,264
+4,657
+6% +$111K ﹤0.01% 1186
2025
Q4 		$2.18M Buy
81,607
+1,866
+2% +$44.6K ﹤0.01% 1115
2025
Q3 		$1.7M Sell
79,741
-5,433
-6% -$128K ﹤0.01% 1215
2025
Q2 		$1.84M Sell
85,174
-4,778
-5% -$88.8K ﹤0.01% 1138
2025
Q1 		$1.5M Buy
89,952
+6,303
+8% +$115K ﹤0.01% 1281
2024
Q4 		$1.53M Sell
83,649
-3,256
-4% -$52.6K ﹤0.01% 1316
2024
Q3 		$1.34M Buy
86,905
+3,768
+5% +$62.9K ﹤0.01% 1371
2024
Q2 		$1.35M Buy
+83,137
New +$1.34M ﹤0.01% 1286

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return